Northwestern Mutual Wealth Management’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.03K Buy
+85
New +$2.36K ﹤0.01% 3594
2024
Q4
Sell
-24
Closed -$588 3627
2024
Q3
$588 Buy
+24
New +$620 ﹤0.01% 3325
2024
Q1
Sell
-50
Closed -$1.36K 3581
2023
Q4
$1.36K Buy
+50
New +$1.24K ﹤0.01% 3114
2022
Q1
Sell
-23
Closed -$2K 3107
2021
Q4
$2K Buy
+23
New +$1.97K ﹤0.01% 2932

Other funds holding BEAM

Northwestern Mutual Wealth Management's BEAM Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 85 shares worth $2.03K. The stake represents ﹤0.01% of the portfolio and ranks #3594 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in BEAM as recently as Q3 2024.

Northwestern Mutual Wealth Management first reported a position in BEAM in Q4 2021 and has held it in 4 quarters since. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Northwestern Mutual Wealth Management held 85 shares of Beam Therapeutics worth $2.03K as of Q1 2026.
  • Beam Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3594 holding.
  • Northwestern Mutual Wealth Management first reported a position in Beam Therapeutics in Q4 2021 and has held it in 4 quarters since.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.